How do you give MAXIPIME IV?

How do you give MAXIPIME IV?

MAXIPIME should be administered intravenously over approximately 30 minutes. Recommended Dosage Schedule for MAXIPIME in Patients with CrCL >60 mL/min. **or until resolution of neutropenia.

How do you administer MAXIPIME?

Dosage For Adults Administer MAXIPIME intravenously over approximately 30 minutes. *or until resolution of neutropenia. In patients whose fever resolves but who remain neutropenic for more than 7 days, the need for continued antimicrobial therapy should be re-evaluated frequently.

How do you administer cefepime IV?

Cefepime injection comes as a powder to be mixed with liquid, or as a premixed product, to be injected intravenously (into a vein) over a period of 30 minutes. Cefepime injection can also be given intramuscularly (into a muscle). It is usually given every 8 or 12 hours for 7 to 10 days.

What fluids is cefepime compatible with?

Cefepime for injection vials are compatible at concentrations between 1 mg per mL and 40 mg per mL with the following intravenous infusion fluids: 0.9% Sodium Chloride Injection, 5% and 10% Dextrose Injection, M/6 Sodium Lactate Injection, 5% Dextrose and 0.9% Sodium Chloride Injection, Lactated Ringers and 5% Dextrose …

What is maxipime used to treat?

Cefepime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Is maxipime a penicillin?

Cefepime is a cephalosporin (SEF a low spor in) antibiotic. Cefepime injection is used to treat many kinds of bacterial infections, including severe or life-threatening forms.

How do you dilute IV cefepime?

Reconstitution and Dilution Reconstitute ADD-Vantage vials containing 1 or 2 g of cefepime with 50 or 100 mL of 0.9% sodium chloride or 5% dextrose injection according to the manufacturer’s directions.

How fast can you infuse cefepime?

Administer Cefepime for Injection USP and Dextrose Injection USP intravenously over approximately 30 minutes. Intermittent intravenous infusion with a Y-type administration set can be accomplished with compatible solutions.

Can cefepime be given IV push?

Cefepime Administered by IV Push Associated With Increased Risk of Neutropenia. More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia.

What type of antibiotic is maxipime?

This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

What type of drug is maxipime?

What is the other name for Maxipime?

How much Cefepime is in a Maxipime injection?

MAXIPIME for Injection is supplied for intramuscular or intravenous administration in strengths equivalent to 500 mg, 1 g, and 2 g of cefepime. (See DOSAGE AND ADMINISTRATION.) MAXIPIME is a sterile, dry mixture of cefepime hydrochloride and L-arginine. It contains the equivalent of not less than 90 percent and not more than

How often should Maxipime be taken for renal impairment?

Dosage Adjustments in Patients with Renal Impairment. The dosage of Maxipime for hemodialysis patients is 1 g on Day 1 followed by 500 mg every 24 hours for the treatment of all infections except febrile neutropenia, which is 1 g every 24 hours.

When to adjust the dose of Maxipime for creatinine clearance?

Adjust the dose of Maxipime in patients with creatinine clearance less than or equal to 60 mL/min to compensate for the slower rate of renal elimination. In these patients, the recommended initial dose of Maxipime should be the same as in patients with CrCL greater than 60 mL/min except in patients undergoing hemodialysis.

What should be the dosage of Maxipime for add-vantage?

MAXIPIME in ADD-Vantage vials are stable at concentrations of 10 to 40 mg per mL in 5% Dextrose Injection or 0.9% Sodium Chloride Injection for 24 hours at controlled room temperature 20°C to 25°C (68°F to 77°F) or 7 days in a refrigerator 2°C to 8°C (36°F to 46°F). MAXIPIME admixture compatibility information is summarized in Table 4.